The DETECT study is the first randomised controlled trial comparing Minder System implants to standard care monitoring.

Here are four things to know. 1. Levetiracetam is intended to treat partial onset seizures related to epilepsy. 2. The tablets are a generic equivalent to UCB’s brand name drug Keppra XR. 3. Sales of ...

According to a real-world study, cenobamate was effective in patients with drug-resistant epilepsy (DRE), with 49.3% of patients achieved a 50% or greater reduction in seizure frequency at 3 months.

Under the initiative, AIIMS will offer monitoring for commonly used anti-epileptic drugs such as phenobarbitone, ...

Chardan Research initiated coverage on Wednesday of Bright Minds Biosciences Inc. (NASDAQ:DRUG), an epilepsy drug developer. The company’s lead product, BMB-101, is a novel scaffold 5-HT2C Gq-protein ...

Bright Minds Biosciences Inc. (DRUG) has been able to initiate its phase 2 BREAKTHROUGH study using its 5-HT2C agonist BMB-101 for the treatment of adult patients with classic Absence Epilepsy and ...

Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant ...

A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers at the University of Wisconsin–Madison. The drug, called ...

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers. If the drug proves viable for human patients, it would be ...

India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy, the ...